|
1
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Magee CJ, Ghaneh P and Neoptolemos JP:
Surgical and medical therapy for pancreatic carcinoma. Best Pract
Res Clin Gastroenterol. 16:435–455. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yeo TP, Hruban RH, Leach SD, Wilentz RE,
Sohn TA, Kern SE, Iacobuzio-Donahue CA, Maitra A, Goggins M, Canto
MI, et al: Pancreatic cancer. Curr Probl Cancer. 26:176–275. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Warshaw AL and Fernández-del Castillo C:
Pancreatic carcinoma. N Engl J Med. 326:455–465. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fahy BN, Schlieman M, Virudachalam S and
Bold RJ: AKT inhibition is associated with chemosensitisation in
the pancreatic cancer cell line MIA-PaCa-2. Br J Cancer.
89:391–397. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schlieman MG, Fahy BN, Ramsamooj R,
Beckett L and Bold RJ: Incidence, mechanismand prognostic value of
activated AKT in pancreas cancer. Br J Cancer. 89:2110–2115. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang H and Tindall DJ: Dynamic FoxO
transcription factors. J Cell Sci. 120:2479–2487. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gomes AR, Brosens JJ and Lam EW: Resist or
die: FOXO transcription factors determine the cellular response to
chemotherapy. Cell Cycle. 7:3133–3136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kops GJ, Medema RH, Glassford J, Essers
MA, Dijkers PF, Coffer PJ, Lam EW and Burgering BM: Control of cell
cycle exit and entry by protein kinase B-regulated forkhead
transcription factors. Mol Cell Biol. 22:2025–2036. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schmidt M, Fernandez de Mattos S, van der
Horst A, Klompmaker R, Kops GJ, Lam EW, Burgering BM and Medema RH:
Cell cycle inhibition by FoxO forkhead transcription factors
involves downregulation of cyclin D. Mol Cell Biol. 22:7842–7852.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Burgering BM and Medema RH: Decisions on
life and death: FOXO forkhead transcription factors are in command
when PKB/Akt is off duty. J Leukoc Biol. 73:689–701. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Greer EL and Brunet A: FOXO transcription
factors at the interface between longevity and tumor suppression.
Oncogene. 24:7410–7425. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Boreddy SR, Pramanik KC and Srivastava SK:
Pancreatic tumor suppression by benzyl isothiocyanate is associated
with inhibition of PI3K/AKT/FOXO pathway. Clin Cancer Res.
17:1784–1795. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Minami M, Nishio K, Ajioka Y, Kyushima H,
Shigeki K, Kinjo K, Yamada K, Nagai M, Satoh K and Sakurai Y:
Identification of Curcuma plants and curcumin content level by DNA
polymorphisms in the trnS-trnfM intergenic spacer in chloroplast
DNA. J Nat Med. 63:75–79. 2009. View Article : Google Scholar
|
|
15
|
Shehzad A, Lee J and Lee YS: Curcumin in
various cancers. Biofactors. 39:56–68. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Goel A, Kunnumakkara AB and Aggarwal BB:
Curcumin as 'Curecumin': From kitchen to clinic. Biochem Pharmacol.
75:787–809. 2008. View Article : Google Scholar
|
|
17
|
Sa G, Guo Y and Stacey DW: The regulation
of S phase initiation by p27Kip1 in NIH3T3 cells. Cell Cycle.
4:618–627. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Datta SR, Brunet A and Greenberg ME:
Cellular survival: A play in three Akts. Genes Dev. 13:2905–2927.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Manju V and Nalini N: Chemopreventive
efficacy of ginger, a naturally occurring anticarcinogen during the
initiation, post-initiation stages of 1,2 dimethylhydrazine-induced
colon cancer. Clin Chim Acta. 358:60–67. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dorai T and Aggarwal BB: Role of
chemopreventive agents in cancer therapy. Cancer Lett. 215:129–140.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sinha R, Anderson DE, McDonald SS and
Greenwald P: Cancer risk and diet in India. J Postgrad Med.
49:222–228. 2003.PubMed/NCBI
|
|
22
|
Guo H, Xu YM, Ye ZQ, Yu JH and Hu XY:
Curcumin induces cell cycle arrest and apoptosis of prostate cancer
cells by regulating the expression of IkappaBalpha, c-Jun and
androgen receptor. Pharmazie. 68:431–434. 2013.PubMed/NCBI
|
|
23
|
Yin Z and Sun J: Curcumin induces human
SKOV3 cell apoptosis via the activation of Rho-kinase. Eur J
Gynaecol Oncol. 35:433–437. 2014.PubMed/NCBI
|
|
24
|
Lv ZD, Liu XP, Zhao WJ, Dong Q, Li FN,
Wang HB and Kong B: Curcumin induces apoptosis in breast cancer
cells and inhibits tumor growth in vitro and in vivo. Int J Clin
Exp Pathol. 7:2818–2824. 2014.PubMed/NCBI
|
|
25
|
Dilnawaz F and Sahoo SK: Enhanced
accumulation of curcumin and temozolomide loaded magnetic
nanoparticles executes profound cytotoxic effect in glioblastoma
spheroid model. Eur J Pharm Biopharm. 85:452–462. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Temraz S, Mukherji D and Shamseddine A:
Potential targets for colorectal cancer prevention. Int J Mol Sci.
14:17279–17303. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nessa MU, Beale P, Chan C, Yu JQ and Huq
F: Studies on combination of platinum drugs cisplatin and
oxaliplatin with phytochemicals anethole and curcumin in ovarian
tumour models. Anticancer Res. 32:4843–4850. 2012.PubMed/NCBI
|
|
28
|
Yogosawa S, Yamada Y, Yasuda S, Sun Q,
Takizawa K and Sakai T: Dehydrozingerone, a structural analogue of
curcumin, induces cell-cycle arrest at the G2/M phase and
accumulates intracellular ROS in HT-29 human colon cancer cells. J
Nat Prod. 75:2088–2093. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang X, Tang N, Hadden TJ and Rishi AK:
Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta.
1813:1978–1986. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Uddin S, Hussain AR, Siraj AK, Manogaran
PS, Al-Jomah NA, Moorji A, Atizado V, Al-Dayel F, Belgaumi A,
El-Solh H, et al: Role of phosphatidylinositol 39-kinase/AKT
pathway in diffuse large B-cell lymphoma survival. Blood.
108:4178–4186. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Medema RH, Kops GJ, Bos JL and Burgering
BM: AFX-like Forkhead transcription factors mediate cell cycle
regulation by Ras and PKB through p27kip1. Nature. 404:782–787.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Seoane J, Le HV, Shen L, Anderson SA and
Massagué J: Integration of Smad and forkhead pathways in the
control of neuroepithelial and glioblastoma cell proliferation.
Cell. 117:211–223. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Evans-Anderson HJ, Alfieri CM and Yutzey
KE: Regulation of cardiomyocyte proliferation and myocardial growth
during development by FOXO transcription factors. Circ Res.
102:686–694. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Katayama K, Nakamura A, Sugimoto Y, Tsuruo
T and Fujita N: FOXO transcription factor-dependent p15 (INK4b) and
p19 (INK4d) expression. Oncogene. 27:1677–1686. 2008. View Article : Google Scholar
|
|
35
|
Hamacher R, Schmid RM, Saur D and
Schneider G: Apoptotic pathways in pancreatic ductal
adenocarcinoma. Mol Cancer. 7:642008. View Article : Google Scholar : PubMed/NCBI
|
